Related Experiment Video
Updated: Nov 7, 2025

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
Published on: September 8, 2023
Accessible LAMP-Enabled Rapid Test (ALERT) for Detecting SARS-CoV-2
Ali Bektaş1, Michael F Covington1,2, Guy Aidelberg3
1Oakland Genomics Center, 355 30th Street, Oakland, CA 94609, USA.
A new Accessible LAMP-Enabled Rapid Test (ALERT) offers a rapid, inexpensive, and sensitive DIY method for detecting viral RNA, including SARS-CoV-2, addressing limitations of current COVID-19 testing. This workflow provides accurate results within 60 minutes.
Area of Science:
- Biotechnology
- Molecular Biology
- Infectious Disease Diagnostics
Background:
- Current COVID-19 diagnostic methods like PCR and antigen tests have limitations including cost, turnaround time, lab dependency, and false negative rates.
- The pandemic exposed critical needs for accessible, scalable, and accurate population-level infection detection.
- Existing molecular amplification techniques often require complex laboratory infrastructure and trained personnel.
Purpose of the Study:
- To develop an inexpensive, simple, and rapid do-it-yourself (DIY) workflow for detecting viral RNA.
- To achieve high sensitivity and specificity for viral detection comparable to or exceeding existing methods.
- To create a versatile platform adaptable for various targets and point-of-care applications.
Main Methods:
- Developed a 60-minute workflow utilizing reverse transcription loop-mediated isothermal amplification (RT-LAMP) for viral RNA detection.
- Incorporated features like wax-encapsulated reagents for shelf-stability, sequence-specific QUASR for improved specificity, and magnetic concentration for enhanced sensitivity.
- Integrated a quality control target and enabled multiplexing for co-detection of other respiratory viruses.
Main Results:
- Achieved high sensitivity (0.1 to 2 viral particles/μL) and specificity (>97% true negative rate) for viral RNA detection.
- Demonstrated a 60-minute turnaround time for results from nasal swabs or saliva.
- The ALERT system showed increased shelf-life and ambient temperature storage capabilities.
Conclusions:
- The Accessible LAMP-Enabled Rapid Test (ALERT) provides a robust, sensitive, and specific molecular diagnostic solution.
- ALERT addresses key limitations of current infectious disease testing, offering a viable option for at-home and point-of-care use.
- The flexible design of ALERT allows for easy adaptation to detect various pathogens and nucleic acid markers beyond SARS-CoV-2.
More Related Videos
07:08A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
Published on: April 6, 2021
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021